Efficacy and safety of the H1N1 monovalent vaccine in renal-transplant recipients and dialysis patients

Human Vaccines

Volumn 7, Issue 8, 2011, Pages 868-873

  Beaudreuil, Séverine ^a   Krivine, Anne ^b   Hebibi, Hadia ^a   Ducot, Béatrice ^a   Mazet, Anne Aurélie ^a   Taouffik, Yacine ^a   Seidowsky, Alexandre ^a   Jacquet, Antoine ^a   Lorenzo, Hans Kristian ^a   Charpentier, Bernard ^a   Francois, Hélène ^a   Durrbach, Antoine ^a  

^a BICÊTRE HOSPITAL   (France)

^b Institut Cochin   (France)

Author keywords

Dialysis; H1N1 disease; Monovalent vaccination; Renal transplantation

Indexed keywords

AZATHIOPRINE; BELATACEPT; CYCLOSPORIN; INFLUENZA VACCINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS; THYMOCYTE ANTIBODY; IMMUNOLOGICAL ADJUVANT; VIRUS ANTIBODY;

2009 H1N1 INFLUENZA; ABSENCE OF SIDE EFFECTS; ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; GRAFT RECIPIENT; HEMAGGLUTINATION INHIBITION TEST; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA VACCINATION; KIDNEY TRANSPLANTATION; MALE; PERITONEAL DIALYSIS; SEROCONVERSION; SEX DIFFERENCE; TREATMENT RESPONSE; BLOOD; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MIDDLE AGED; RENAL REPLACEMENT THERAPY; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RENAL DIALYSIS; VACCINATION;

EID: 85046979624     PISSN: 15548600     EISSN: 15548619     Source Type: Journal    
DOI: 10.4161/hv.7.8.16083     Document Type: Article

References (31)

1. Advisory Committee on Immunization Practices (ACIP). Use of influenza A (H1N1) 2009 monovalent vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2009; 58:1-8; PMID:19713882.
2. Greenberg M.E., et al. Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009; 361:2405-13; PMID:19745216; DOI:10.1056/ NEJMoa0907413.
3. Marcelli D., Marelli C., Richards N. Influenza A. (H1N1)v pandemic in the dialysis population: first wave results from an international survey. Nephrol Dial Transplant 2009; 24:3566-72; PMID:19846392; DOI:10.1093/ndt/gfp557.
4. Kumar D., Michaels M.G., Morris M.I., Green M., Avery R.K., Liu C., et al. Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study. Lancet Infect Dis 2010; 10:521-6; PMID:20620116; DOI:10.1016/S1473-3099(10)70133-X.
5. Seville M.T., et al. 2009 H1N1 influenza in hospitalized transplant recipients. Transplantation 2010; 90:571-4; PMID:20555304; DOI:10.1097/TP. 0b013e3181e86af0.
6. Kunisaku K.M., et al. Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality and vaccine responses. Lancet Infect Dis 2009; 9:493-504; PMID:19628174; DOI:10.1016/S1473-3099(09)70175-6.
7. Clark T.W., et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361:2424-35; PMID:19745215; DOI:10.1056/NEJMoa0907650.
8. Plennevaux E., et al. Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials. Lancet 2010; 375:41-8; PMID:20018365; DOI:10.1016/S0140-6736(09) 62026-2.
9. Kumar D., et al. Guidance on novel influenza A/H1N1 in solid organ transplant recipients. Am J Transplant year 2010; 10:18-25.
10. Lindemann M., et al. ELISpot assay as a sensitive tool to detect cellular immunity following influenza vaccination in lung transplant recipients. J Heart Lung Transplant 2004; 23:1175-1181; PMID:15477112.
11. Labriola L., et al. Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients. Nephrol Dial Transplant 2011; 26:1424-8; PMID:21273236; DOI:10.1093/ndt/gfq782.
12. Dikow R., et al. Immunogenicity and efficay in hemododialysis patients of an AS03A-adjuvanted vaccine for 2009 pandemic influenza A (H1N1): A nonrandomized trial. Am J Kidney Dis 2011.
13. Girndt M., et al. Molecular aspects of T- and B-cell function in uremia. Kidney Int Suppl 2001; 78:206-211; PMID:11169012.
14. Eleftheriadis T., et al. Disturbances of acquired immunity in hemodialysis patients. Semin Dial 2007; 20:440-51; PMID:17897251; DOI:10.1111/j.1525-139X.2007.00283.x.
15. Cavdar C., et al. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 2003; 37:71-6; PMID:12745749; DOI:10.1080/00365590310008749.
16. Blumberg E.A., et al. The immunogenicity of influenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 1996; 22:295-302; PMID:8838186; DOI:10.1093/clinids/22.2.295.
17. Versluis D.J., et al. Impairment of the immune response to influenza vaccination in renal transplant recipients by cyclosporine, but not azathioprine. Transplantation 1986; 42:376-9; PMID:3532450; DOI:10.1097/ 00007890-198610000-00009.
18. Smith K.G., et al. Suppression of the humoral immune response by mycophenolate mofetil. Nephrol Dial Transplant 1998; 13:160-4; PMID:9481733; DOI:10.1093/ndt/13.1.160.
19. Salles M.J., et al. Influenza virus vaccination in kidney transplant recipients: serum antibody response to different immunosuppressive drugs. Clin Transplant 2010; 24:17-23; PMID:19758368; DOI:10.1111/j.1399-0012.2009.01095.x.
20. Scharpe J., et al. Influenza vaccination is efficacious and safe in renal transplant recipients. Am J Transplant 2008; 8:332-7; PMID:18162092; DOI:10.1111/j.1600-6143.2007.02066.x.
21. Jacobson I.M., et al. Immunogenicity of hepatitis B vaccine in renal transplant recipients. Transplantation 1985; 39:393-5; PMID:3157246; DOI:10.1097/00007890-198504000-00011.
22. Lefebure A.F., et al. Immunogenicity of a recombinant DNA hepatitis B vaccine in renal transplant patients. Vaccine 1993; 11:397-9; PMID:8470423; DOI:10.1016/0264-410X(93)90278-6.
23. Kumar D., et al. Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients. J Infect Dis 2003; 187:1639-45; PMID:12721944; DOI:10.1086/374784.
24. Nicolas J.F., et al. Intradermal epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008; 7:1201-14; PMID:18844594; DOI:10.1586/14760584.7.8.1201.
25. Chi R.C., et al. Immunogenicity and safety of intradermal influenza vaccination in healthy older adults. CID 2010;50:1331-1337
26. Morellon E., et al. Immunogenicity and safety of intradermal influenza vaccination in renal transplant patients who were non-responders to conventionnal influenza vaccination. Vaccine 2010; 28:6885-6890
27. Evison J., et al. Randomiezd, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. CID 2009; 48:1402-1409DOI:10.1086/598193.
28. Antonen J.A., et al. Adequate seroresponse to influenza vaccination in dialysis patients. Nephron 2000; 86:56-61; PMID:10971154; DOI:10.1159/000045713.
29. Siriaksorn S., et al. Prevalence of protective antibody against hepatitis B virus in HIV-infected children with immune recovery after highly active antiretroviral therapy. Vaccine 2006; 24:3095-9; PMID:16488516; DOI:10.1016/j.vaccine.2006.01.045.
30. Abzug M.J., et al. Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy. J Infect Dis 2009; 200:935-46; PMID:19663708; DOI:10.1086/605448.
31. Kendal A.P., Pereira M.S., Skehel J. Concepts and procedures for laboratory-based influenza surveillance. Atlanta: Center for Disease Control 1982.